Corelab Data Services
Clinilabs Drug Development Corporation is a leading provider of core laboratory data services for clinical trials. Our high-performance platform connecting investigator sites and sponsors around the world to a validated and secure electronic data environment in the United States. Clinilabs corelab data services center hosts seven core laboratories that aggregate and centrally process data from multicenter clinical trials.
Corelab Data Services Value
The value of our corelab data services is its ability to reduce statistical variance in clinical datasets. By processing data centrally, rather than having data scored or reported by individual investigator sites, we are able to significantly reduce variation. Furthermore, enabling sponsors to determine the differences between treatment conditions more accurately in a clinical trial. In some cases, sponsors who have suffered a failed trial have successfully repeated the same study using our corelab processing.
Industry-Leading Expertise
Clinilabs’ corelab data services offer industry-leading operational expertise, physical and electronic security systems, as well as a high-performance network infrastructure to enable the centralized capture and processing of clinical trial data. The corelab provides clients with a turnkey solution, offering investigator sites qualification, device management, study-wide SOPs, centralized processing with rapid turnaround times in addition to 24/7 helpdesk system.
Clinilabs provides the following data types:
I have no ideology. My ideology is health.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
The best way to predict the future is to invent it.
Drugs don’t work in patients who don’t take them.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
Good information is the best medicine.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
The reward for work well done is the opportunity to do more.
One never notices what has been done; one can only see what remains to be done.
The pace of discovery is going unbelievably fast.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
If you think compliance is expensive, try non-compliance.
All truths are easy to understand once they are discovered; the point is to discover them.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
I am not accustomed to saying anything with certainty after only one or two observations.
There is so much more to be done; the patients are waiting.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
One sometimes finds what one is not looking for.